TY - JOUR AU - Linehan, W. M. AU - Srinivasan, R. AU - Schmidt, L. S. PY - 2010 DA - 2010// TI - The genetic basis of kidney cancer: a metabolic disease JO - Nature reviews VL - 7 ID - Linehan2010 ER - TY - CHAP PY - 2010 DA - 2010// BT - Institute N.C. kidney cancer [online] ID - ref2 ER - TY - JOUR AU - Hervouet, E. AU - Demont, J. AU - Pecina, P. AU - Vojtiskova, A. AU - Houstek, J. AU - Simonnet, H. AU - Godinot, C. PY - 2005 DA - 2005// TI - A new role for the von Hippel-Lindau tumor suppressor protein: stimulation of mitochondrial oxidative phosphorylation complex biogenesis JO - Carcinogenesis VL - 26 UR - https://doi.org/10.1093/carcin/bgi001 DO - 10.1093/carcin/bgi001 ID - Hervouet2005 ER - TY - JOUR AU - Semenza, G. L. PY - 2003 DA - 2003// TI - Targeting HIF-1 for cancer therapy JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1187 DO - 10.1038/nrc1187 ID - Semenza2003 ER - TY - JOUR AU - Chan, D. A. AU - Kawahara, T. L. AU - Sutphin, P. D. AU - Chang, H. Y. AU - Chi, J. T. AU - Giaccia, A. J. PY - 2009 DA - 2009// TI - Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment JO - Cancer Cell VL - 15 UR - https://doi.org/10.1016/j.ccr.2009.04.010 DO - 10.1016/j.ccr.2009.04.010 ID - Chan2009 ER - TY - JOUR AU - Chan, D. A. AU - Giaccia, A. J. PY - 2010 DA - 2010// TI - PHD2 in tumour angiogenesis JO - Br J Cancer VL - 103 UR - https://doi.org/10.1038/sj.bjc.6605682 DO - 10.1038/sj.bjc.6605682 ID - Chan2010 ER - TY - JOUR AU - Appelhoff, R. J. AU - Tian, Y. M. AU - Raval, R. R. AU - Turley, H. AU - Harris, A. L. AU - Pugh, C. W. AU - Ratcliffe, P. J. AU - Gleadle, J. M. PY - 2004 DA - 2004// TI - Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor JO - The J biological chemistry VL - 279 UR - https://doi.org/10.1074/jbc.M406026200 DO - 10.1074/jbc.M406026200 ID - Appelhoff2004 ER - TY - JOUR AU - Bruick, R. K. AU - McKnight, S. L. PY - 2001 DA - 2001// TI - A conserved family of prolyl-4-hydroxylases that modify HIF JO - Science VL - 294 UR - https://doi.org/10.1126/science.1066373 DO - 10.1126/science.1066373 ID - Bruick2001 ER - TY - JOUR AU - Soilleux, E. J. AU - Turley, H. AU - Tian, Y. M. AU - Pugh, C. W. AU - Gatter, K. C. AU - Harris, A. L. PY - 2005 DA - 2005// TI - Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues JO - Histopathology VL - 47 UR - https://doi.org/10.1111/j.1365-2559.2005.02280.x DO - 10.1111/j.1365-2559.2005.02280.x ID - Soilleux2005 ER - TY - JOUR AU - Wenger, R. H. AU - Camenisch, G. AU - Stiehl, D. P. AU - Katschinski, D. M. PY - 2009 DA - 2009// TI - HIF prolyl-4-hydroxylase interacting proteins: consequences for drug targeting JO - Curr Pharm Des VL - 15 UR - https://doi.org/10.2174/138161209789649411 DO - 10.2174/138161209789649411 ID - Wenger2009 ER - TY - JOUR AU - Metzen, E. AU - Berchner-Pfannschmidt, U. AU - Stengel, P. AU - Marxsen, J. H. AU - Stolze, I. AU - Klinger, M. AU - Huang, W. Q. AU - Wotzlaw, C. AU - Hellwig-Burgel, T. AU - Jelkmann, W. PY - 2003 DA - 2003// TI - Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing JO - J Cell Sci VL - 116 UR - https://doi.org/10.1242/jcs.00318 DO - 10.1242/jcs.00318 ID - Metzen2003 ER - TY - JOUR AU - Place, T. L. AU - Fitzgerald, M. P. AU - Venkataraman, S. AU - Vorrink, S. U. AU - Case, A. J. AU - Teoh, M. L. AU - Domann, F. E. PY - 2011 DA - 2011// TI - Aberrant promoter CpG methylation is a mechanism for impaired PHD3 expression in a diverse set of malignant cells JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0014617 DO - 10.1371/journal.pone.0014617 ID - Place2011 ER - TY - JOUR AU - Liu, Y. AU - Huo, Z. AU - Yan, B. AU - Lin, X. AU - Zhou, Z. N. AU - Liang, X. AU - Zhu, W. AU - Liang, D. AU - Li, L. AU - Zhao, H. PY - 2010 DA - 2010// TI - Prolyl hydroxylase 3 interacts with Bcl-2 to regulate doxorubicin-induced apoptosis in H9c2 cells JO - Biochem Biophys Res Commun VL - 401 UR - https://doi.org/10.1016/j.bbrc.2010.09.037 DO - 10.1016/j.bbrc.2010.09.037 ID - Liu2010 ER - TY - JOUR AU - Tennant, D. A. AU - Gottlieb, E. PY - 2010 DA - 2010// TI - HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression JO - J Mol Med (Berl) VL - 88 UR - https://doi.org/10.1007/s00109-010-0627-0 DO - 10.1007/s00109-010-0627-0 ID - Tennant2010 ER - TY - JOUR AU - Pan, Y. AU - Mansfield, K. D. AU - Bertozzi, C. C. AU - Rudenko, V. AU - Chan, D. A. AU - Giaccia, A. J. AU - Simon, M. C. PY - 2007 DA - 2007// TI - Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro JO - Mol Cell Biol VL - 27 UR - https://doi.org/10.1128/MCB.01223-06 DO - 10.1128/MCB.01223-06 ID - Pan2007 ER - TY - JOUR AU - Metzen, E. AU - Zhou, J. AU - Jelkmann, W. AU - Fandrey, J. AU - Brune, B. PY - 2003 DA - 2003// TI - Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases JO - Molecular biology of the cell VL - 14 UR - https://doi.org/10.1091/mbc.E02-12-0791 DO - 10.1091/mbc.E02-12-0791 ID - Metzen2003 ER - TY - JOUR AU - Chowdhury, R. AU - Flashman, E. AU - Mecinovic, J. AU - Kramer, H. B. AU - Kessler, B. M. AU - Frapart, Y. M. AU - Boucher, J. L. AU - Clifton, I. J. AU - McDonough, M. A. AU - Schofield, C. J. PY - 2011 DA - 2011// TI - Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1) JO - J molecular biology VL - 410 UR - https://doi.org/10.1016/j.jmb.2011.04.075 DO - 10.1016/j.jmb.2011.04.075 ID - Chowdhury2011 ER - TY - JOUR AU - Finley, L. W. AU - Carracedo, A. AU - Lee, J. AU - Souza, A. AU - Egia, A. AU - Zhang, J. AU - Teruya-Feldstein, J. AU - Moreira, P. I. AU - Cardoso, S. M. AU - Clish, C. B. PY - 2011 DA - 2011// TI - SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization JO - Cancer Cell VL - 19 UR - https://doi.org/10.1016/j.ccr.2011.02.014 DO - 10.1016/j.ccr.2011.02.014 ID - Finley2011 ER - TY - JOUR AU - Sun, M. AU - Lughezzani, G. AU - Perrotte, P. AU - Karakiewicz, P. I. PY - 2010 DA - 2010// TI - Treatment of metastatic renal cell carcinoma JO - Nat Rev Urol VL - 7 UR - https://doi.org/10.1038/nrurol.2010.57 DO - 10.1038/nrurol.2010.57 ID - Sun2010 ER - TY - JOUR AU - Rapisarda, A. AU - Shoemaker, R. H. AU - Melillo, G. PY - 2009 DA - 2009// TI - Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.24.10145 DO - 10.4161/cc.8.24.10145 ID - Rapisarda2009 ER - TY - JOUR AU - Lippman, S. M. AU - Klein, E. A. AU - Goodman, P. J. AU - Lucia, M. S. AU - Thompson, I. M. AU - Ford, L. G. AU - Parnes, H. L. AU - Minasian, L. M. AU - Gaziano, J. M. AU - Hartline, J. A. PY - 2009 DA - 2009// TI - Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JO - JAMA VL - 301 UR - https://doi.org/10.1001/jama.2008.864 DO - 10.1001/jama.2008.864 ID - Lippman2009 ER - TY - JOUR AU - Chintala, S. AU - Toth, K. AU - Cao, S. AU - Durrani, F. A. AU - Vaughan, M. M. AU - Jensen, R. L. AU - Rustum, Y. M. PY - 2010 DA - 2010// TI - Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha JO - Cancer Chemother Pharmacol VL - 66 UR - https://doi.org/10.1007/s00280-009-1238-8 DO - 10.1007/s00280-009-1238-8 ID - Chintala2010 ER - TY - JOUR AU - Yin, M. B. AU - Li, Z. R. AU - Toth, K. AU - Cao, S. AU - Durrani, F. A. AU - Hapke, G. AU - Bhattacharya, A. AU - Azrak, R. G. AU - Frank, C. AU - Rustum, Y. M. PY - 2006 DA - 2006// TI - Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiogenesis JO - Oncogene VL - 25 UR - https://doi.org/10.1038/sj.onc.1209073 DO - 10.1038/sj.onc.1209073 ID - Yin2006 ER - TY - JOUR AU - Bhattacharya, A. AU - Seshadri, M. AU - Oven, S. D. AU - Toth, K. AU - Vaughan, M. M. AU - Rustum, Y. M. PY - 2008 DA - 2008// TI - Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0212 DO - 10.1158/1078-0432.CCR-08-0212 ID - Bhattacharya2008 ER - TY - JOUR AU - Cao, S. AU - Durrani, F. A. AU - Rustum, Y. M. PY - 2004 DA - 2004// TI - Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-03-0268 DO - 10.1158/1078-0432.CCR-03-0268 ID - Cao2004 ER - TY - JOUR AU - Kessler, J. AU - Hahnel, A. AU - Wichmann, H. AU - Rot, S. AU - Kappler, M. AU - Bache, M. AU - Vordermark, D. PY - 2010 DA - 2010// TI - HIF-1alpha inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-605 DO - 10.1186/1471-2407-10-605 ID - Kessler2010 ER - TY - JOUR AU - Vaughan, M. M. AU - Toth, K. AU - Chintala, S. AU - Rustum, Y. M. PY - 2010 DA - 2010// TI - Double Immunohistochemical Staining Method for HIF-1alpha and its Regulators PHD2 and PHD3 in Formalin-fixed Paraffin-embedded Tissues JO - Appl Immunohistochem Mol Morphol VL - 18 UR - https://doi.org/10.1097/PAI.0b013e3181d6bd59 DO - 10.1097/PAI.0b013e3181d6bd59 ID - Vaughan2010 ER - TY - JOUR AU - Qian, D. Z. AU - Kachhap, S. K. AU - Collis, S. J. AU - Verheul, H. M. AU - Carducci, M. A. AU - Atadja, P. AU - Pili, R. PY - 2006 DA - 2006// TI - Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-4598 DO - 10.1158/0008-5472.CAN-05-4598 ID - Qian2006 ER - TY - JOUR AU - Kong, H. S. AU - Lee, S. AU - Beebe, K. AU - Scroggins, B. AU - Gupta, G. AU - Lee, M. J. AU - Jung, Y. J. AU - Trepel, J. AU - Neckers, L. PY - 2010 DA - 2010// TI - Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2alpha in clear cell renal carcinoma JO - Mol Pharmacol VL - 78 UR - https://doi.org/10.1124/mol.110.066514 DO - 10.1124/mol.110.066514 ID - Kong2010 ER - TY - JOUR AU - Chintala, S. AU - Tan, J. AU - Gautam, R. AU - Rusiniak, M. E. AU - Guo, X. AU - Li, W. AU - Gahl, W. A. AU - Huizing, M. AU - Spritz, R. A. AU - Hutton, S. PY - 2007 DA - 2007// TI - The Slc35d3 gene, encoding an orphan nucleotide sugar transporter, regulates platelet-dense granules JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-08-040196 DO - 10.1182/blood-2006-08-040196 ID - Chintala2007 ER - TY - JOUR AU - Agresti, A. AU - Coull, B. A. PY - 1998 DA - 1998// TI - Approximate is better than exact for interval estimation of binomial proportions JO - The Am Statistician VL - 52 ID - Agresti1998 ER - TY - JOUR AU - Gordan, J. D. AU - Lal, P. AU - Dondeti, V. R. AU - Letrero, R. AU - Parekh, K. N. AU - Oquendo, C. E. AU - Greenberg, R. A. AU - Flaherty, K. T. AU - Rathmell, W. K. AU - Keith, B. PY - 2008 DA - 2008// TI - HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma JO - Cancer Cell VL - 14 UR - https://doi.org/10.1016/j.ccr.2008.10.016 DO - 10.1016/j.ccr.2008.10.016 ID - Gordan2008 ER - TY - JOUR AU - Kim, J. H. AU - Jung, C. W. AU - Cho, Y. H. AU - Lee, J. AU - Lee, S. H. AU - Kim, H. Y. AU - Park, J. AU - Park, J. O. AU - Kim, K. AU - Kim, W. S. PY - 2005 DA - 2005// TI - Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma JO - Oncology reports VL - 13 ID - Kim2005 ER - TY - JOUR AU - Nyhan, M. J. AU - El Mashad, S. M. AU - O'Donovan, T. R. AU - Ahmad, S. AU - Collins, C. AU - Sweeney, P. AU - Rogers, E. AU - O'Sullivan, G. C. AU - McKenna, S. L. PY - 2010 DA - 2010// TI - VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin JO - Anal Cell Pathol (Amst) VL - 33 UR - https://doi.org/10.1155/2010/562491 DO - 10.1155/2010/562491 ID - Nyhan2010 ER - TY - JOUR AU - Hatzimichael, E. AU - Dasoula, A. AU - Shah, R. AU - Syed, N. AU - Papoudou-Bai, A. AU - Coley, H. M. AU - Dranitsaris, G. AU - Bourantas, K. L. AU - Stebbing, J. AU - Crook, T. PY - 2010 DA - 2010// TI - The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia JO - European J haematology VL - 84 UR - https://doi.org/10.1111/j.1600-0609.2009.01344.x DO - 10.1111/j.1600-0609.2009.01344.x ID - Hatzimichael2010 ER - TY - JOUR AU - Astuti, D. AU - Ricketts, C. J. AU - Chowdhury, R. AU - McDonough, M. A. AU - Gentle, D. AU - Kirby, G. AU - Schlisio, S. AU - Kenchappa, R. S. AU - Carter, B. D. AU - Kaelin, W. G. PY - 2011 DA - 2011// TI - Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility JO - Endocrine-related cancer VL - 18 UR - https://doi.org/10.1677/ERC-10-0113 DO - 10.1677/ERC-10-0113 ID - Astuti2011 ER - TY - JOUR AU - Yan, M. AU - Rayoo, M. AU - Takano, E. A. AU - Fox, S. B. PY - 2009 DA - 2009// TI - BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression JO - Br J Cancer VL - 101 UR - https://doi.org/10.1038/sj.bjc.6605287 DO - 10.1038/sj.bjc.6605287 ID - Yan2009 ER - TY - JOUR AU - Sinha, I. AU - Null, K. AU - Wolter, W. AU - Suckow, M. A. AU - King, T. AU - Pinto, J. T. AU - Sinha, R. PY - 2012 DA - 2012// TI - Methylseleninic acid down regulates hypoxia inducible factor-1alpha in invasive prostate cancer JO - Int J cancer VL - 130 UR - https://doi.org/10.1002/ijc.26141 DO - 10.1002/ijc.26141 ID - Sinha2012 ER - TY - JOUR AU - Kassam, S. AU - Goenaga-Infante, H. AU - Maharaj, L. AU - Hiley, C. T. AU - Juliger, S. AU - Joel, S. P. PY - 2011 DA - 2011// TI - Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines JO - Cancer Chemother Pharmacol VL - 68 UR - https://doi.org/10.1007/s00280-011-1649-1 DO - 10.1007/s00280-011-1649-1 ID - Kassam2011 ER - TY - JOUR AU - Cai, Q. AU - Verma, S. C. AU - Kumar, P. AU - Ma, M. AU - Robertson, E. S. PY - 2010 DA - 2010// TI - Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0009720 DO - 10.1371/journal.pone.0009720 ID - Cai2010 ER - TY - JOUR AU - To, K. K. AU - Huang, L. E. PY - 2005 DA - 2005// TI - Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1 JO - The Journal of biological chemistry VL - 280 UR - https://doi.org/10.1074/jbc.M504342200 DO - 10.1074/jbc.M504342200 ID - To2005 ER - TY - JOUR AU - Maxwell, P. H. AU - Wiesener, M. S. AU - Chang, G. W. AU - Clifford, S. C. AU - Vaux, E. C. AU - Cockman, M. E. AU - Wykoff, C. C. AU - Pugh, C. W. AU - Maher, E. R. AU - Ratcliffe, P. J. PY - 1999 DA - 1999// TI - The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis JO - Nature VL - 399 UR - https://doi.org/10.1038/20459 DO - 10.1038/20459 ID - Maxwell1999 ER - TY - JOUR AU - Ohh, M. AU - Park, C. W. AU - Ivan, M. AU - Hoffman, M. A. AU - Kim, T. Y. AU - Huang, L. E. AU - Pavletich, N. AU - Chau, V. AU - Kaelin, W. G. PY - 2000 DA - 2000// TI - Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein JO - Nat Cell Biol VL - 2 UR - https://doi.org/10.1038/35017054 DO - 10.1038/35017054 ID - Ohh2000 ER - TY - JOUR AU - Cheng, J. AU - Kang, X. AU - Zhang, S. AU - Yeh, E. T. PY - 2007 DA - 2007// TI - SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia JO - Cell VL - 131 UR - https://doi.org/10.1016/j.cell.2007.08.045 DO - 10.1016/j.cell.2007.08.045 ID - Cheng2007 ER - TY - JOUR AU - Liu, Y. V. AU - Baek, J. H. AU - Zhang, H. AU - Diez, R. AU - Cole, R. N. AU - Semenza, G. L. PY - 2007 DA - 2007// TI - RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha JO - Mol Cell VL - 25 UR - https://doi.org/10.1016/j.molcel.2007.01.001 DO - 10.1016/j.molcel.2007.01.001 ID - Liu2007 ER - TY - JOUR AU - Isaacs, J. S. AU - Jung, Y. J. AU - Mimnaugh, E. G. AU - Martinez, A. AU - Cuttitta, F. AU - Neckers, L. M. PY - 2002 DA - 2002// TI - Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway JO - The J biological chem VL - 277 UR - https://doi.org/10.1074/jbc.M204733200 DO - 10.1074/jbc.M204733200 ID - Isaacs2002 ER - TY - JOUR AU - Koh, M. Y. AU - Darnay, B. G. AU - Powis, G. PY - 2008 DA - 2008// TI - Hypoxia-associated factor, a novel E3-ubiquitin ligase, binds and ubiquitinates hypoxia-inducible factor 1alpha, leading to its oxygen-independent degradation JO - Mol Cell Biol VL - 28 UR - https://doi.org/10.1128/MCB.00773-08 DO - 10.1128/MCB.00773-08 ID - Koh2008 ER - TY - JOUR AU - Zhou, Y. D. AU - Kim, Y. P. AU - Mohammed, K. A. AU - Jones, D. K. AU - Muhammad, I. AU - Dunbar, D. C. AU - Nagle, D. G. PY - 2005 DA - 2005// TI - Terpenoid tetrahydroisoquinoline alkaloids emetine, klugine, and isocephaeline inhibit the activation of hypoxia-inducible factor-1 in breast tumor cells JO - J Nat Prod VL - 68 UR - https://doi.org/10.1021/np050029m DO - 10.1021/np050029m ID - Zhou2005 ER - TY - JOUR AU - Semenza, G. L. PY - 2009 DA - 2009// TI - HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery JO - Curr Pharm Des VL - 15 UR - https://doi.org/10.2174/138161209789649402 DO - 10.2174/138161209789649402 ID - Semenza2009 ER - TY - JOUR AU - Zhang, H. AU - Qian, D. Z. AU - Tan, Y. S. AU - Lee, K. AU - Gao, P. AU - Ren, Y. R. AU - Rey, S. AU - Hammers, H. AU - Chang, D. AU - Pili, R. PY - 2008 DA - 2008// TI - Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth JO - Proc Natl Acad Sci USA VL - 105 UR - https://doi.org/10.1073/pnas.0809763105 DO - 10.1073/pnas.0809763105 ID - Zhang2008 ER - TY - JOUR AU - Rapisarda, A. AU - Uranchimeg, B. AU - Sordet, O. AU - Pommier, Y. AU - Shoemaker, R. H. AU - Melillo, G. PY - 2004 DA - 2004// TI - Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-3139 DO - 10.1158/0008-5472.CAN-03-3139 ID - Rapisarda2004 ER - TY - JOUR AU - Patiar, S. AU - Harris, A. L. PY - 2006 DA - 2006// TI - Role of hypoxia-inducible factor-1alpha as a cancer therapy target JO - Endocr Relat Cancer VL - 13 UR - https://doi.org/10.1677/erc.1.01290 DO - 10.1677/erc.1.01290 ID - Patiar2006 ER - TY - JOUR AU - An, Z. AU - Jiang, P. AU - Wang, X. AU - Moossa, A. R. AU - Hoffman, R. M. PY - 1999 DA - 1999// TI - Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection JO - Clin Exp Metastasis VL - 17 UR - https://doi.org/10.1023/A:1006654600095 DO - 10.1023/A:1006654600095 ID - An1999 ER - TY - JOUR AU - Hoffman, R. M. PY - 1999 DA - 1999// TI - Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic JO - Invest New Drugs VL - 17 UR - https://doi.org/10.1023/A:1006326203858 DO - 10.1023/A:1006326203858 ID - Hoffman1999 ER - TY - JOUR AU - Hoffman, R. M. PY - 2005 DA - 2005// TI - The multiple uses of fluorescent proteins to visualize cancer in vivo JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1717 DO - 10.1038/nrc1717 ID - Hoffman2005 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/12/293/prepub UR - http://www.biomedcentral.com/1471-2407/12/293/prepub ID - ref56 ER -